Nigella sativa and its bioactive compound thymoquinone in burn therapy.
Nigella sativa and Its Bioactive Compound Thymoquinone in Burn Therapy: Mechanisms, Efficacy, and Safety.
AI Summary
Key Findings
Abstract
Burn injuries represent a worldwide public health concern. Nigella sativa (NS), a herbal medicinal plant, widely used in Ayurveda, Unani, and Siddha holds potential to address this issue. This review evaluated the potential of NS extract and its key component, Thymoquinone (TQ), in accelerating burn wound healing, focusing on their mechanisms, safety, and efficacy. Studies were retrieved from PubMed, Google Scholar, and ScienceDirect using keywords "Nigella sativa," "Thymoquinone," "burns," and "wound healing." Reports were screened for suitability, and the scientific name was verified on www.worldfloraonline.org. NS extract and TQ accelerate burn wound healing in vitro and in vivo through various mechanisms involving anti-inflammatory, anti-oxidative, anti-microbial, and tissue regenerative effects. TQ achieved 91.35% wound closure in NIH/3T3 cells (mouse fibroblasts) and wound closure rate of 2.35±0.05% in 3T3-CCL92 cells (fibroblasts from mouse embryos). It also reduced oxidative stress and inflammation in murine burn models. Nanoformulations of TQ showed higher safety (LD₅₀: 300-2000 mg/kg) than pure TQ (LD₅₀: 50-300 mg/kg). A Phase I trial confirmed the safety of black cumin oil (5% TQ) at 200 mg/day for 90 days in healthy adults. Therefore, formulations based on NS extract and TQ can manage burn injuries and be extrapolated into clinical settings.
Affiliation
Sonali Karhana
External References
- PubMed ID:
- 41575220
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.